English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90452/105769 (86%)
Visitors : 11933476      Online Users : 392
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    ASIA unversity > 護理學院 > 護理學系 > 期刊論文 >  Item 310904400/110812


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/110812


    Title: Protective Effects of Preactivated and Disaggregated Shape-Changed Platelets and Human Embryonic Stem Cell-Derived Exosomes Improve Neurological Function and Attenuate Brain Infarct after Acute Ischemic Stroke
    Authors: 陳怡伶;Chen,Yi-Ling;林元平;Lin,Yuan-Ping;宋沛勳;Sung,Pei-Hsun;邵佩琳;Shao,Pei Lin;葉漢根;Yip,Hon-Kan;蔡慧玲;Chua,Sarah
    Contributors: 護理學系
    Date: 2017-12
    Issue Date: 2018-04-03 09:51:13 (UTC+8)
    Abstract: Background:
    This investigation tested the hypothesis that preactivated and disaggregated shape-changedplatelets (PreD-SCP) and human embryonic stem cell-derived exosomes (hESC-Exo) treatments can reduce brain-infarct area (BIA) in rat with reservation of neurological function following acute ischemic stroke (AIS) induced by left iddle-cerebral artery occlusion.
    Materials and Methods:
    Adult-male Sprague-Dawley rats (n=24) were randomly divided into group 1 (sham-control), 2
    (AIS), 3 [AIS + PreD-SCP (3.0x108
    cells)] and 4 (AIS + hESC-Exo, 100 μg). PreD-SCP and hESC-Exo
    were administered intravenously at 2/6/24 hours after the AIS procedure for animals in group
    3 and 4, respectively. All animals were euthanized by day-28 post-AIS.
    Results:
    Brain infarct area (BIA) measured by histopathology was significantly larger in group 2 than
    that in other groups, and significantly larger in group 3 and 4 than that in group 1 (p<0.01), but
    it showed no difference between group 3 and 4. The improvement in neurological function
    displayed a pattern opposite to that of BIA by days 3/7/14/28 after AIS in the four groups (all
    p<0.01). The protein expressions of inflammation (MMP-9/TNF-α/Cox-2/iNOS), oxidative stress
    (oxidized protein/NOX-1/NOX-2) and apoptosis (cleaved-caspase-3/PARP/mitochondrial-Bax)
    exhibited a pattern identical to that of BIA among the four groups (all p<0.01). The cellular
    levels of inflammatory (CD14+/CD68+/GFAP+), DNA-damage/apoptotic (γ-H2AX+/apoptotic
    nuclei) biomarkers exhibited an identical pattern, whereas the neuron/myelin-sheath integrity
    markers (NeuN+/BMP+ cells) expressed an opposite pattern compared to that of BIA in the
    four groups (all p<0.05). The expressions of endothelial cell markers at cellular (CD31+/vWF+)and protein (CD31/eNOS/vWF) levels and the number of small vessels showed an opposite
    pattern compared to that of BIA in all groups, whereas the endothelial progenitor cell markers
    at cellular/protein (CXCR4/SDF-1α) levels progressively increased from groups 1 to 4 (all
    p<0.001).
    Conclusion:
    PreD-SCP and hESC-Exo treatments significantly protected the brain from AIS damage and
    improved neurological outcome.
    Keywords:
    Acute ischemic stroke, Preactivated and disaggregated shape-changed platelets, Human
    embryonic stem cell-derived exosome, Inflammation, Oxidative stress, Angiogenesis
    Relation: Neuropsychiatry
    Appears in Collections:[護理學系] 期刊論文

    Files in This Item:

    File SizeFormat
    index.html0KbHTML113View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback